Rowan Dunne is a Writer/Editor at Metals Daily and Mugglehead. With a focus on cannabis and psychedelics, as well as energy and mining, Rowan explores the intersection of social issues and healthcare, particularly in relation to alternative medicine and diagnostics. Rowan's work has been featured in prominent publications such as Metals Daily and Mugglehead.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Rowan Dunne's coverage is heavily focused on press releases and private sector announcements related to the business, energy, and mining industries. To effectively pitch to Rowan, consider providing exclusive access or insights into new developments within these sectors.
Given the nature of the articles covered by Rowan, he would likely be interested in receiving news about notable appointments or strategic moves within companies operating in the mentioned industries. Providing detailed information about technological advancements or significant production milestones could also capture his attention.
It's important to note that while Rowan does not have a specific geographic focus, many of the topics covered are international in scope. Therefore, pitches should emphasize global relevance and impact.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Rowan Dunne
The renowned institution claims this is the ‘largest psychedelic brain imaging study of its kind to date'
By: Rowan Dunne
The space company's stock surged by over 50% on the New York Stock Exchange after the news broke
Mistral made in onto TIME Magazine's list of 100 Most Influential Companies last year
The company was previously known as Unrivaled Brands before a rebranding last January
It will cost just under US$3,000 Missouri's nighttime technology developer, Symphony Sleep, is launching a novel product at the Las Vegas Market next week.
The marketing ploy contest is being put on by Sneakers Cannabis — a Mazor Collective brand
By: Rowan Dunne
It was trained by examining over 1,500 CT scans Artificial intelligence has once again proved its value in detecting lung cancer.
The latest data from Health Canada shows a 98% year-over-year spike
By: Rowan Dunne
The company's prescription marijuana label ‘IndiMed' is now launching its ‘Island Sweet Skunk' sativa
By: Rowan Dunne
Trump's newly announced US$500-billion-dollar AI initiative could make custom-tailored vaccines a reality
(833) 317-6278 
